Distinct Reproductive Risk Profiles for Intrinsic-Like Breast Cancer Subtypes: Pooled Analysis of Population-Based Studies
- PMID: 35723569
- PMCID: PMC9949579
- DOI: 10.1093/jnci/djac117
Distinct Reproductive Risk Profiles for Intrinsic-Like Breast Cancer Subtypes: Pooled Analysis of Population-Based Studies
Abstract
Background: Reproductive factors have been shown to be differentially associated with risk of estrogen receptor (ER)-positive and ER-negative breast cancer. However, their associations with intrinsic-like subtypes are less clear.
Methods: Analyses included up to 23 353 cases and 71 072 controls pooled from 31 population-based case-control or cohort studies in the Breast Cancer Association Consortium across 16 countries on 4 continents. Polytomous logistic regression was used to estimate the association between reproductive factors and risk of breast cancer by intrinsic-like subtypes (luminal A-like, luminal B-like, luminal B-HER2-like, HER2-enriched-like, and triple-negative breast cancer) and by invasiveness. All statistical tests were 2-sided.
Results: Compared with nulliparous women, parous women had a lower risk of luminal A-like, luminal B-like, luminal B-HER2-like, and HER2-enriched-like disease. This association was apparent only after approximately 10 years since last birth and became stronger with increasing time (odds ratio [OR] = 0.59, 95% confidence interval [CI] = 0.49 to 0.71; and OR = 0.36, 95% CI = 0.28 to 0.46 for multiparous women with luminal A-like tumors 20 to less than 25 years after last birth and 45 to less than 50 years after last birth, respectively). In contrast, parous women had a higher risk of triple-negative breast cancer right after their last birth (for multiparous women: OR = 3.12, 95% CI = 2.02 to 4.83) that was attenuated with time but persisted for decades (OR = 1.03, 95% CI = 0.79 to 1.34, for multiparous women 25 to less than 30 years after last birth). Older age at first birth (Pheterogeneity < .001 for triple-negative compared with luminal A-like breast cancer) and breastfeeding (Pheterogeneity < .001 for triple-negative compared with luminal A-like breast cancer) were associated with lower risk of triple-negative breast cancer but not with other disease subtypes. Younger age at menarche was associated with higher risk of all subtypes; older age at menopause was associated with higher risk of luminal A-like but not triple-negative breast cancer. Associations for in situ tumors were similar to luminal A-like.
Conclusions: This large and comprehensive study demonstrates a distinct reproductive risk factor profile for triple-negative breast cancer compared with other subtypes, with implications for the understanding of disease etiology and risk prediction.
© The Author(s) 2022. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Figures
Comment in
-
Can Breast Cancer Prevention Strategies Be Tailored to Biologic Subtype and Unique Reproductive Windows?J Natl Cancer Inst. 2022 Dec 8;114(12):1575-1576. doi: 10.1093/jnci/djac114. J Natl Cancer Inst. 2022. PMID: 35723566 Free PMC article. No abstract available.
References
-
- Kelsey JL, Bernstein L. Epidemiology and prevention of breast cancer. Annu Rev Public Health. 1996;17:47-67. - PubMed
-
- Barnard ME, Boeke CE, Tamimi RM. Established breast cancer risk factors and risk of intrinsic tumor subtypes. Biochim Biophys Acta. 2015;1856(1):73-85. - PubMed
-
- Lambertini M, Santoro L, Del Mastro L, et al. Reproductive behaviors and risk of developing breast cancer according to tumor subtype: a systematic review and meta-analysis of epidemiological studies. Cancer Treat Rev. 2016;49:65-76. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 CA148667/CA/NCI NIH HHS/United States
- NU58DP006344/DP/NCCDPHP CDC HHS/United States
- G1000143/MRC_/Medical Research Council/United Kingdom
- R01 CA100374/CA/NCI NIH HHS/United States
- 14136 /CRUK_/Cancer Research UK/United Kingdom
- UM1 CA186107/CA/NCI NIH HHS/United States
- U19 CA148065/CA/NCI NIH HHS/United States
- Z01-CP010119/CA/NCI NIH HHS/United States
- U01 CA164973/CA/NCI NIH HHS/United States
- U01 CA179715/CA/NCI NIH HHS/United States
- MR/M012190/1/MRC_/Medical Research Council/United Kingdom
- UM1 CA164917/CA/NCI NIH HHS/United States
- Z01-ES049030/ES/NIEHS NIH HHS/United States
- HHSN261201800032C/CA/NCI NIH HHS/United States
- 1000143/MRC_/Medical Research Council/United Kingdom
- CA63464/NH/NIH HHS/United States
- UM1 CA164973/CA/NCI NIH HHS/United States
- P30 ES010126/ES/NIEHS NIH HHS/United States
- C8221/A19170/CRUK_/Cancer Research UK/United Kingdom
- MR/N003284/1/MRC_/Medical Research Council/United Kingdom
- U01-CA199277/NH/NIH HHS/United States
- R01CA64277/NH/NIH HHS/United States
- 29186/CRUK_/Cancer Research UK/United Kingdom
- R37 CA070867/CA/NCI NIH HHS/United States
- CA97396/NH/NIH HHS/United States
- U01 CA176726/CA/NCI NIH HHS/United States
- KOMEN/Susan G. Komen/United States
- HHSN261201800009I/CA/NCI NIH HHS/United States
- N01CN25403/CA/NCI NIH HHS/United States
- HHSN261201800015I/CA/NCI NIH HHS/United States
- 20861/CRUK_/Cancer Research UK/United Kingdom
- P30 CA033572/CA/NCI NIH HHS/United States
- Z01 ES049030/ImNIH/Intramural NIH HHS/United States
- P30 CA023100/CA/NCI NIH HHS/United States
- C570/A16491/CRUK_/Cancer Research UK/United Kingdom
- R01 CA177150/CA/NCI NIH HHS/United States
- P01 CA87969/NH/NIH HHS/United States
- G0401527/MRC_/Medical Research Council/United Kingdom
- UM1 CA176726/NH/NIH HHS/United States
- R01 CA077398/CA/NCI NIH HHS/United States
- P30 CA068485/CA/NCI NIH HHS/United States
- U54 CA156733/CA/NCI NIH HHS/United States
- Z01 CP010119/ImNIH/Intramural NIH HHS/United States
- 5NU58DP006344/CC/CDC HHS/United States
- R01CA100374/NH/NIH HHS/United States
- HHSN261201800032I/CA/NCI NIH HHS/United States
- P30 CA68485/NH/NIH HHS/United States
- N01 CN025403/CA/NCI NIH HHS/United States
- UM1 CA164920/CA/NCI NIH HHS/United States
- HHSN261201800015C/CA/NCI NIH HHS/United States
- 209057/WT_/Wellcome Trust/United Kingdom
- UM1 CA182910/CA/NCI NIH HHS/United States
- 16561/CRUK_/Cancer Research UK/United Kingdom
- P50 CA058223/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
